Dolby Laboratories, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Dolby Laboratories (NYSE: DLB) granted inducement equity awards to its new CEO, Marc Whitten, under its 2026 Inducement Stock Plan. The awards include $10M in time-based restricted stock units and 600,000 performance-based units tied to stock price hurdles. The plan was approved by the board and is required to be publicly announced under NYSE rules.
Dolby Laboratories (DLB) maintained 'Buy' rating by Rosenblatt with $85 target. GF Value™ suggests 24.5% undervaluation at $62.41. GF Score™ 77/100 highlights strong financials but low momentum. Insiders sold $1.66M shares recently.
Dolby Laboratories (DLB) reported that Ryan Nicholson, VP and CAO, sold 1,183 shares of Class A Common Stock on 2026-08-25 at $65.2773 per share. Nicholson now holds 34,453 shares, including 19,303 restricted stock units. The sale was not part of a Rule 10b5-1 trading plan.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning DLB (Dolby Laboratories, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent DLB coverage spans financial news, technology and corporate actions.
In the last 30 days, DLB insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($545K). The most active reporter was Nicholson Ryan, VP, CAO and Corp. Controller, with 1 filing. 50% of those filings were made under pre-arranged Rule 10b5-1 plans.
The award may slightly dilute existing shareholders but signals confidence in new leadership.
Analyst rating sustainment and higher price target suggest upside potential.
Small insider sell by a senior executive; limited price impact.
Leadership change may influence strategic direction and investor sentiment.
A new pro-sports deployment expands Dolby’s live sports footprint, but the article provides no financial terms or adoption metrics.
AlphAI scores every news story that mentions DLB with an AI model for sentiment and relevance, and aggregates insider trades from Dolby Laboratories, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Dolby Laboratories (NYSE: DLB) granted inducement equity awards to its new CEO, Marc Whitten, under its 2026 Inducement Stock Plan. The awards include $10M in time-based restricted stock units and 600,000 performance-based units tied to stock price hurdles. The plan was approved by the board and is required to be publicly announced under NYSE rules.
1 min readDolby Laboratories (DLB) maintained 'Buy' rating by Rosenblatt with $85 target. GF Value™ suggests 24.5% undervaluation at $62.41. GF Score™ 77/100 highlights strong financials but low momentum. Insiders sold $1.66M shares recently.
2 min readDolby Laboratories (DLB) reported that Ryan Nicholson, VP and CAO, sold 1,183 shares of Class A Common Stock on 2026-08-25 at $65.2773 per share. Nicholson now holds 34,453 shares, including 19,303 restricted stock units. The sale was not part of a Rule 10b5-1 trading plan.
1 min readDolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Dolby Laboratories Announces Leadership Transition Kevin Yeaman to Retire from Dolby Marc Whitten Named President, Chief Executive Officer and Director of Dolby SAN FRANCISCO, Calif., August 27, 2026 — Dolby Laboratories, Inc. (NYSE: DLB), today announced a new chapt
2 min readDolby Laboratories (NYSE:DLB) said it partnered with the Seattle Seahawks to deliver live sports streaming in Dolby Vision, debuting Dolby OptiView in pro sports. The company expects the deal to improve streaming quality and deepen fan engagement, potentially affecting future live sports broadcasting standards. Dolby supplies imaging and audio tech for TV and live entertainment.
4 min readThe article reviews Q2 earnings for design software stocks. PTC (PTC) reported $600m revenue, down 6.8% YoY, missing analyst expectations by 1.3%, with billings and ARR misses and weaker full-year guidance. Procore (PCOR) revenue rose to $375.2m (+15.8%), beating estimates. Cadence (CDNS) revenue was $1.58b (+24.2%), beating estimates and next-quarter EPS guidance.
6 min readDolby Laboratories (NYSE: DLB) and the Seattle Seahawks announced a partnership to integrate Dolby OptiView with Dolby Vision into the Seahawks Mobile App and Seahawks.com. The Seahawks said they will be the first team to add Dolby OptiView with Dolby Vision, with Dolby also becoming an Official Partner.
2 min readThe article lists recent tech M&A deals. zvoove said it acquired the IP behind Pixi AI Agent, an AI WhatsApp onboarding and support tool, for undisclosed terms, to expand automation for staffing customers in Switzerland. Dolby Laboratories bought a video-compression IP portfolio with 683 assets and 250 patents, also undisclosed. Cloud9 acquired Chpter, adding 4,500 businesses and 1 million transactions.
4 min readFlorida Atlantic University said Dolby Laboratories acquired a video-compression patent portfolio developed via a partnership with OP Solutions. The assets relate to Versatile Video Coding (VVC, H.266), finalized in 2020, which can cut video data needs about 50% versus HEVC at similar quality. The portfolio includes 683 IP assets and 16 U.S. patents declared essential to VVC, licensed via the Access Advance pool.
3 min readDolby Laboratories and Hisense announced a rollout of Dolby Vision 2, starting with select Hisense TV models. The format will reach North America, Europe, and APAC via firmware updates, supporting existing Dolby Vision content and new titles across film, TV, games, and live sports. Streaming platforms including CANAL+, iQIYI, and Peacock plan to use it. Initial support covers Hisense UX, UR9, UR8, and U7 series.
2 min read
